United States · FDA National Drug Code directory
Buspirone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-181_8692aee8-7eb4-4cbb-8a31-3ecc49660195
- Product NDC
- 68382-181
- Form
- TABLET
- Composition / generic term
- Buspirone hydrochloride
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140503
- Source listing expiry
- 20261231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68382-181-01) · 68382-181-01
- 500 TABLET in 1 BOTTLE (68382-181-05) · 68382-181-05
- 1000 TABLET in 1 BOTTLE (68382-181-10) · 68382-181-10
- 100 BLISTER PACK in 1 CARTON (68382-181-77) / 1 TABLET in 1 BLISTER PACK (68382-181-30) · 68382-181-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →